Jeffrey James Roix
Direktor/Vorstandsmitglied bei Stingray Bio Ltd.
Ursprung des Netzwerks ersten Grades von Jeffrey James Roix
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom.
12
| Private Company | Investment Managers | 12 |
Opal Therapeutics Ltd.
Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opal Oncology Ltd. operates as a pharmaceutical company. It develops drugs for cancer. The company was founded in 2012 and is headquartered in Cambridge, the United Kingdom.
3
| Private Company | Pharmaceuticals: Major | 3 |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Stingray Bio Ltd.
Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Stingray Bio Ltd. is a British biotechnology research company founded in 2020. The company is based in Brighton, UK. The company provides research services in the field of biotechnology.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jeffrey James Roix
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Oxford | College/University | Undergraduate Degree Corporate Officer/Principal | |
PA Consulting Group Ltd.
PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Consultant / Advisor | |
University of Salford | College/University | Graduate Degree | |
University of Cambridge | College/University | Masters Business Admin Graduate Degree | |
York University | College/University | Undergraduate Degree | |
Oxford Drug Design Ltd.
Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Founder Director/Board Member | |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
East Carolina University | College/University | Doctorate Degree | |
University of London | College/University | Doctorate Degree | |
Newcastle University | College/University | Doctorate Degree | |
The Johns Hopkins University | College/University | Corporate Officer/Principal | |
Sheffield Hallam University | College/University | Undergraduate Degree | |
ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Birmingham | College/University | Graduate Degree | |
University of Zurich | College/University | Doctorate Degree | |
Nagoya University | College/University | Graduate Degree | |
Keele University | College/University | Undergraduate Degree | |
Aitua Ltd.
Aitua Ltd. Investment ManagersFinance Aitua Ltd. engages in the commercialization of intellectual properties of companies in the field of life sciences. It provides support to new bio-ventures by investing in the initial stage. The company was founded in June 2006 and is headquartered in Cambridge, the United Kingdom. | Investment Managers | Chief Executive Officer | |
PBL-Ventures
PBL-Ventures Investment ManagersFinance PBL-Ventures is the business start-up and mentoring arm of Plant Bioscience Ltd founded in 1994. The firm is headquartered in the UK. | Investment Managers | Director/Board Member | |
Sentinel Oncology Ltd.
Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Founder | |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sage Healthcare Ltd.
Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Sage Healthcare Ltd. provides management consulting services to the healthcare industry. The firm's services include strategic analysis and development; mergers and acquisitions; business development, support, and planning; corporate partnering; licensing and venturing; technology and compound brokerage; valuations and value-enhancement planning; forecasting; risk assessment and due diligence; and commercial and technical assessment. The company was founded in 1995 and is headquartered in Great Shelford, GB. | Miscellaneous Commercial Services | Director/Board Member | |
Locate Bio Ltd.
Locate Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Oval Medical Technologies Ltd.
Oval Medical Technologies Ltd. Medical SpecialtiesHealth Technology Oval Medical Technologies Ltd. manufactures drug delivery devices focusing on vials, prefilled syringes, and autoinjectors. It provides an environment for the storage of all drugs including fragile biologics. The company was founded by Matthew Young in 2009 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
CFA Society of the UK
CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Founder | |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | President | |
HORIZON DISCOVERY GROUP PLC | Medical Specialties | Director/Board Member Founder | |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Consultant / Advisor | |
Exonate Ltd.
Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Medical/Nursing Services | Director/Board Member Founder Chairman | |
Meltwind Advisory LLP | Corporate Officer/Principal | ||
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Avocet 66 Ltd.
Avocet 66 Ltd. Financial ConglomeratesFinance Avocet 66 Ltd. is a British financial intermediary company founded in 2017. | Financial Conglomerates | Director/Board Member | |
Peregrine 66 Ltd.
Peregrine 66 Ltd. Financial ConglomeratesFinance Peregrine 66 Ltd. is a British investment services company founded in 2017. The private company is based in London, UK. The company provides investment services. | Financial Conglomerates | Director/Board Member | |
Suntail 66 Ltd.
Suntail 66 Ltd. Financial ConglomeratesFinance Suntail 66 Ltd. provides financial intermediary services. The private company is based in London, UK. | Financial Conglomerates | Director/Board Member | |
Start Codon Ltd.
Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member | |
Iguana Investments Ltd. (United Kingdom)
Iguana Investments Ltd. (United Kingdom) Investment ManagersFinance Iguana Investments Ltd. is a private company based in the United Kingdom that provides investment advice. The British company was founded in 2019 by Thameema Hamza, Chris Reid, and Fahd Ahmed. Fahd Ahmed has been the CEO since 2019. | Investment Managers | Founder | |
Nanna Therapeutics Ltd.
Nanna Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nanna Therapeutics Ltd. engages in development of pharmaceutical products. It provides drugs for combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. The company is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | President | |
Enhanc3D Genomics Ltd.
Enhanc3D Genomics Ltd. BiotechnologyHealth Technology Enhanc3D Genomics is a private functional genomics company based in Cambridge, UK. Enhanc3D Genomics is developing a technology to unlock the full potential of the three-dimensional organization of the human genome. The British company's focus is on the non-coding regions of the genome, aiming to identify disease-associated genetic interactions and revolutionize target and biomarker discovery. The company's unique approach has the potential to make precision medicine an everyday reality for patients. Enhanc3D Genomics Ltd. was founded by Mikhail Spivakov, Peter Fraser, and Stefan Schönfelder. The CEO is Hazel Jones. | Biotechnology | Chairman | |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Founder |
Statistik
International
Vereinigtes Königreich | 40 |
Vereinigte Staaten | 6 |
Japan | 3 |
Kanada | 2 |
Schweiz | 2 |
Sektoral
Consumer Services | 14 |
Health Technology | 13 |
Commercial Services | 12 |
Finance | 9 |
Technology Services | 4 |
Operativ
Director/Board Member | 70 |
Corporate Officer/Principal | 21 |
Founder | 17 |
Chairman | 15 |
Chief Executive Officer | 11 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Nigel Pitchford | 29 |
Jonathan Milner | 26 |
Christopher Torrance | 13 |
Catherine Beech | 13 |
Sunil Shah | 13 |
William Graham Richards | 11 |
Robert G. Boyle | 6 |
Neil Torbett | 6 |
Cengiz Tarhan | 5 |
David Barrett | 5 |
Chris Reid | 5 |
Prashanth Shah | 4 |
Andy Morley | 4 |
Gayathri Sadasivam | 2 |
Charli Batley | 1 |
- Börse
- Insiders
- Jeffrey James Roix
- Unternehmensverbindungen